Aptevo Therapeutics

Price & Volume

Stats

See more
52W Range
$3.80-$100.59
Market Cap
$6.1M
Shares Short
87,845

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$345,000
Diluted EPS
$1,488.13

About

CEO
Mr. Jeffrey G. Lamothe CA
CFO
Ms. Daphne L. Taylor CPA
Address
2401 4th Avenue, Seattle, WA, United States, 98121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
33